API Docs
All documentation Fundamental API Live (Delayed) API EOD Historical API Intraday API Real-Time (Websockets) API Financial News API Delisted Data API
Solutions
New & Popular APIs
Show all APIs Fundamental Data APIs Historical End-of-Day API Real-time Prices API Financial Events & News API Indices Historical Constituents API 40 000 Stock Market Logos API Forex Data APIs
Other products
Google Sheets Add-on Excel Add-on Coding Libraries (Python, R, etc) Wordpress Add-on
API Marketplace
Community
Academy 152 articles Forum Github 14 repos
Pricing
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. KQ /
  3. 244460.KQ

OLIPASS Corporation (244460 KQ) stock market data APIs

₩4795 -5(-0.1%) as of November 25, 2024
Price chart is built with Anychart

OLIPASS Corporation, a biotech company, focuses on developing therapeutic products in South Korea. The company develops its products using its novel PNA based technologies. Its products pipeline includes SCN9A, a product candidate that is in Phase II clinical trials for the treatment of pain. The company also develops PCSK9 for the treatment of hyper cholesterolemia; VEGF for the treatment of AMD/DR; HIF-1a for chemo/radio-sensitizer treatment; Dystrophin for the treatment of duchenne muscular disease; and PTP1B for the treatment of type II diabetes. It is also involved in the development of CTLA4 immuno-oncology, PD1 immuno-oncology, and NOX4 fibrosis. In addition, the company engages in the collaborative research and development with OliPass Cosmeceuticals for life style management solutions, as well as Target X1 and Target X2. OLIPASS Corporation was founded in 2006 and is headquartered in Yongin-si, South Korea.

OLIPASS Corporation Financial Data Overview

4800
4795
-
5100
4750
4210-10360
18 936 M
4 029 K
5 251 M
-781.9106
0.575
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: '244460',
Type: 'Common Stock',
Name: 'OLIPASS Corporation',
Exchange: 'KQ',
CurrencyCode: 'KRW',
CurrencyName: 'Korean Won',
CurrencySymbol: '₩',
CountryName: 'Korea',
CountryISO: 'KR',
OpenFigi: 'BBG00PYL5X39',
ISIN: NULL,
CIK: NULL,
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: NULL,
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
}

OLIPASS Corporation Fundamental Data is available in our Financial Data APIs

  • Net Revenue 5 251 M
  • EBITDA -14 241 852 416
  • Earnings Per Share
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get OLIPASS Corporation Earnings via APIs

  • Latest Release 2024-06-30
  • EPS/Forecast NaN

Get OLIPASS Corporation End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get OLIPASS Corporation latest news via APIs

Nav1.7 Selective Inhibitor OLP-1002 Shows Strong Efficacy and Long Therapeutic Duration according to Interim Findings from a Phase 2a Study in OA Patients

SEOUL, South Korea, March 16, 2023 /PRNewswire/ -- OliPass Corporation, an RNA therapeutics platform company, disclosed that OLP-1002, a selective inhibitor of Nav1.7 sodium ion channel, showed strong...
  • EFFICACY
  • NEUROPATHIC PAIN
  • OA PAIN
  • OA PATIENTS
  • OSTEOARTHRITIS PATIENTS
  • PAIN KILLERS
  • PHASE 2A
  • PLACEBO EFFECT
  • RNA THERAPEUTICS
  • SELECTIVE INHIBITOR
  • SEOUL
  • SODIUM ION CHANNEL
  • SOUTH KOREA
  • THERAPEUTIC DOSE

Vanda Pharmaceuticals and OliPass Announce Strategic Partnership to Develop Antisense Oligonucleotide Therapeutics

WASHINGTON, Sept. 29, 2022 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) and OliPass Corporation (OliPass) (KOSDAQ: 24460) today announced that they have entered into a research an...
  • ANTISENSE OLIGONUCLEOTIDE
  • ASO
  • CLINICAL TESTING
  • GENE EXPRESSION
  • OLIPASS CORPORATION
  • OPNA
  • PEPTIDE NUCLEIC ACIDS
  • VANDA PHARMACEUTICALS INC
News API is available at any package from $19.99 See full price
Get sample of News API
Do you have any questions?
support@eodhistoricaldata.com